What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company's patients can use AI to look at trends going back five years
Already a member? Log in here
ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
Already a member? Log in here
AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
Already a member? Log in here